Beclomethasone inhaled

Mucomyst) Beclomethasone, nasal (Beconase AQ) Beclomethasone, inhaler (QVAR)... 

B. Change the beclomethasone inhaler to two puffs four times daily. 

D. Instruct the patient to use the beclomethasone inhaler with a spacer. 

HPI KM is a 57-year-old man who presents with severe pain in his right great toe. He states that the pain was first noticeable 2 days ago. This was several days after he stubbed his toe on the leg of the dining room table. He awoke at 3 A.M. with excruciating pain. His toe is swollen, red, and tender to the touch. He states that the pain is constant and does not go away. This is KM s second attack, the first attack occurring 7 months ago, which was successfully treated. The fluid aspirated from the joint is positive for urate crystals. PMH HTN, asthma, family history of gout. Medications Hydrochlorothiazide, beclomethasone inhaler, albuterol inhaler. 

Asthma is a chronic inflammatory disease. Therefore steroids represent the most important and most frequently used medication. Already after the fust treatment, steroids reduce cellular infiltration, inflammation, and the LAR, whereas changes in the EAR require prolonged treatment to lower the existent IgE levels. The mechanisms of steroid actions are complex and only incompletely understood. Besides their general antiinflammatory properties (see chapter glucocorticoids), the reduction of IL-4 and IL-5 production from T-lymphocytes is particularly important for asthma therapy. The introduction of inhaled steroids, which have dramatically limited side effects of steroids, is considered one of the most important advancements in asthma therapy. Inhaled steroids (beclomethasone, budesonide, fluticasone, triamcinolone, momethasone) are used in mild, moderate, and partially also in severe asthma oral steroids are used only in severe asthma and the treatment of status asthmaticus. Minor side effects of most inhaled steroids are hoarseness and candidasis, which are avoided by the prodrug steroid ciclesonide. 

Inhaled steroids (commonly used are beclomethasone, budesonide, triamcinolone, fluticasone, flunisolide) appear to attenuate the inflammatory response, to reduce bronchial hyperreactivity, to decrease exacerbations and to improve health status they may also reduce the risk of myocar dial infar ction, but they do not modify the longterm decline in lung function. Whether- steroids affect mortality remains unclear. Many patients appear to be resistant to steroids and large, long-term trials have shown only limited effectiveness of inhaled corticosteroid ther apy. Certainly, the benefit from steroids is smaller in COPD than in asthma. Topical side-effects of inhaled steroids are oropharyngeal candidiasis and hoarse voice. At the normal doses systemic side-effects of inhaled steroids have not been firmly established. The current recommendation is that the addition of inhaled gluco-coiticosteroids to bronchodilator treatment is appropriate for patients with severe to veiy sever e COPD. 

Corticosteroids, such as beclomethasone (Beclovent), flu-nisolide (AeroBid), and triamcinolone (Azmacort), are given by inhalation and act to decrease the inflammatory process in the airways of the patient with asthma, hi addition, the corticosteroids increase the sensitivity of the p2-receptors. With increased sensitivity of the ( -receptors, the p2-receptor agonist drugs are more effective... 

Malmstrom K, Rodriguez-Gomez G, Guerra J et al. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclometha-sone Study Group. Ann Intern Med 1999 130 487-495. 

The answer is c. (Hardman, p 666.) Inhalation therapy minimizes systemic effects of steroids. Of the agents above, beclomethasone is the only one delivered by mete red-dose inhaler (MDl). 

Beconase (beclomethasone dipropionate) 2 inhalations in each nostril, bid... 

Early IPL studies focused mostly on the metabolism of the bronchodilators and corticosteroids or the pharmacological activity of bronchodilators on the ex vivo preparation. Recently, the absorptive transfer of beclomethasone dipro-prionate (BDP) has been measured following administration to the human lung reperfusion model by two different commercially available inhalers for which human pharmacokinetic data are available for comparison [43],... 

The ventilated and perfused human lung lobe was used as described by Linder and co-workers [74], A twofold difference in the appearance of drug and metabolites in the perfusate was found for the two formulations. Small fractions of the applied dose of BDP were immediately detectable in the perfusate and the amount of the major metabolite, beclomethasone-17-propionate (17-BMP), increased over the experimental period. These observations were similar to the clinical observations that BDP is detected rapidly in the plasma after inhalation and that the appearance of the active metabolite 17-BMP occurs rapidly. The kinetic differences between the formulations were explained on the basis of particle size effects with the conclusion that the discriminatory value of this system to examine the lung pharmacokinetics of inhaled medicines in the absence of systemic effects such as hepatic metabolism was apparent. 

Leach, C.L., Davidson, P.J., and Boudreau, R.J., Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared to CFC-beclomethasone, . Resp. J., 12 1346-1353 (1998). 

Williams, B., Noonan, G., Reiss, T. F., et al. (2001) Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older. Clin. Exp. Allergy. 31, 845-854. 

BECLOMETHASONE Test aerosol by spraying 2 times into the air before first use and in cases where the product has not been used for over 10 days. Rinse mouth after inhalation. 

The aerosol solution does not require shaking. Two actuations of the 40 meg strength should provide a dose comparable to 1 actuation of the 80 meg strength. The recommended dosage relative to CFC-based beclomethasone dipropionate (CFC-BDP) inhalation aerosols is lower because of differences in delivery characteristics between the products. 

Although a variety of interpretations have been issued, reversibility to bronchodilators is considered to be present when the FEV i increases by 200 ml and 12% of the pre-bronchodilator value. Although in the latest GINA guidelines this issue is no longer addressed, the same criteria have been used for evaluation of the response to corticosteroids. A corticosteroid trial compared spirometric tests before and at the end of oral prednisolone (e.g. 30 mg/d) taken for two weeks or a course of inhaled steroid (e.g. beclomethasone 500 pg twice daily or equivalent) taken for six weeks. A positive response to corticosteroids justified prescription of regular inhaled steroid. Subjective improvement as a single efficacy parameter is not considered to be a satisfactory end point. Objective improvement is seen in 10-20% of patients with COPD. 

Nishimura K, Koyama H, Dceda A, Tsukino M, Hajiro T, Mishima M, Izumi T. The effect of high-dose inhaled beclomethasone dipropionate in patients with stable COPD. Chest 1999 115 31-7. 

The corticosteroids are effective in most children and adults with asthma. They are beneficial for the treatment of both acute and chronic aspects of the disease. Inhaled corticosteroids, including triamcinolone ace-tonide (Azmflcort),beclomethasone dipropionate (Beclo-vent, Vancerit), flunisolide AeroBid), and fluticasone (Flovent), are indicated for maintenance treatment of asthma as prophylactic therapy. Inhaled corticosteroids are not effective for relief of acute episodes of severe bronchospasm. Systemic corticosteroids, including prednisone and prednisolone, are used for the short-term treatment of asthma exacerbations that do not respond to (32-adrenoceptor agonists and aerosol corticosteroids. Systemic corticosteroids, along with other treatments, are also used to control status asthmaticus. Because of the side effects produced by systemically administered corticosteroids, they should not be used for maintenance therapy unless all other treatment options have been exhausted. 

A 22-year-old male with a five-year history of bronchial asthma has developed increased frequency and severity of acute asthmatic attacks. A low dose of which inhaled steroid could be added to his treatment regimen Prednisolone Amcinonide Beclomethasone Cortisone Fluocinolone... 

The active component of inhalation aerosol is beclomethasone dipropionate, an anti-inflammatory corticosteroid having the chemical name 9-chloro-ll(beta),17,21-trihy-droxy-16(beta)-methylpregna-l,4-diene-3,20-dione 17,21-dipropionate. It is a pressurized, metered-dose aerosol intended for oral inhalation only. Each unit contains a solution of beclomethasone dipropionate in propellant HFA-134a (1,1,1,2 tetrafluoroethane) and ethanol. The 40-mcg strength delivers 40 meg of beclomethasone dipropionate from the actuator and 50 meg from the valve. The... 

---